GWGuodong Weng

Guodong Weng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guodong Weng has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Irena Zubak

    Department of Neurosurgery, Inselspital, University Hospital and University of Bern, Switzerland

    4 shared publications
  • Johannes Slotboom

    Support Center for Advanced Neuroimaging, University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland

    4 shared publications
  • Piotr Radojewski

    Institute for Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland; Translational Imaging Center, sitem-insel, Bern, Switzerland

    4 shared publications
  • Sulaiman Sheriff

    University of Miami, Miami, FL, United States

    4 shared publications
  • Arsany Hakim

    Institute for Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland

    3 shared publications
  • Johannes Kaesmacher

    Institute for Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland

    3 shared publications

Latest Publications

  • Open Access

    CHEmical-shift selective Adiabatic Pulse (CHEAP): fast and high resolution downfield 3D 1H-MRSI at 7T

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Arsany Hakim, Irena Zubak, Johannes Kaesmacher, Johannes Slotboom

  • Open Access

    CHEmical-shift selective Adiabatic Pulse (CHEAP): Fast and High Resolution Downfield 3D 1H-MRSI at 7T

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Arsany Hakim, Irena Zubak, Johannes Kaesmacher, Johannes Slotboom

    Purpose: The key molecules such as triphosphate (ATP), glutathione (GSH), and homocarnosine (hCs) — central to metabolic processes in the human brain remain elusive or challenging to detect with upfield 1H-MRSI. Traditional 3D 1H-MRSI in vivo faces challenges, including a low signal-to-noise ratio and magnetization transfer effects with water, leading to prolonged measurement times and reduced resolution. To address these limitations, we propose a downfield 3D-MRSI method aimed at measuring downfield metabolites with enhanced spatial resolution, and speed acceptable for clinical practice at 7T.Methods:The CHEmical-shift selective Adiabatic Pulse (CHEAP) technique was integrated into echo-planar spectroscopic imaging (EPSI) readout sequence for downfield metabolite and water reference 3D-MRSI. Five healthy subjects and two glioma patients were scanned to test the feasibility.Results:In this work, CHEAP-EPSI technique is shown to significantly enhance spatial resolution to 0.37 ml while simultaneously reducing the scan time to 10.5 minutes. Its distinct advantages include effective suppression of water and lipid signals, and minimal baseline distortions, making it a valuable tool for research or potentially diagnostic purposes.Conclusions:CHEAP-EPSI improves the detection sensitivity of downfield metabolites like N-acetyl-aspartate (DF7.82) and DF8.18, and offers new possibilities for the study of metabolism in healthy and diseased brain.

  • Open Access

    CHEmical-shift selective Adiabatic Pulse (CHEAP): Fast and High Resolution Downfield 3D 1H-MRSI at 7T

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Arsany Hakim, Irena Zubak, Johannes Kaesmacher, Johannes Slotboom

    The key molecules such as triphosphate (ATP), glutathione (GSH), and homocarnosine (hCs) - central to metabolic processes in the human brain remain elusive or challenging to detect with upfield 1H-MRSI. Traditional 3D 1H-MRSI in vivo faces challenges, including a low signal-to-noise ratio and magnetization transfer effects with water, leading to prolonged measurement times and reduced resolution. To address these limitations, we propose a downfield 3D-MRSI method aimed at measuring downfield metabolites with enhanced spatial resolution, and speed acceptable for clinical practice at 7T. The CHEmical-shift selective Adiabatic Pulse (CHEAP) technique was integrated into echo-planar spectroscopic imaging (EPSI) readout sequence for downfield metabolite and water reference 3D-MRSI. Five healthy subjects and two glioma patients were scanned to test the feasibility. In this work, CHEAP-EPSI technique is shown to significantly enhance spatial the resolution to 0.37 ml while simultaneously reducing the scan time to 10.5 minutes. Its distinct advantages include low specific absorption rate, effective suppression of water and lipid signals, and minimal baseline distortions, making it a valuable tool for research or potentially diagnostic purposes. CHEAP-EPSI improves the detection sensitivity of downfield metabolites like N-acetyl-aspartate (NAA+) and DF8.18 (ATP&GSH+), and offers new possibilities for the study of metabolism in healthy and diseased brain.

  • Open Access

    TensorFit: A torch‐based tool for ultrafast metabolite fitting of large MRSI data sets

    by Federico Turco, Milena Capiglioni, Guodong Weng, Johannes Slotboom

    Purpose: To introduce a tool (TensorFit) for ultrafast and robust metabolite fitting of MRSI data based on Torch's auto‐differentiation and optimization framework.Methods: TensorFit was implemented in Python based on Torch's auto‐differentiation to fit individual metabolites in MRS spectra. The underlying time domain and/or frequency domain fitting model is based on a linear combination of metabolite spectroscopic response. The computational time efficiency and accuracy of TensorFit were tested on simulated and in vivo MRS data and compared against TDFDFit and QUEST.Results: TensorFit demonstrates a significant improvement in computation speed, achieving a 165‐times acceleration compared with TDFDFit and 115 times against QUEST. TensorFit showed smaller percentual errors on simulated data compared with TDFDFit and QUEST. When tested on in vivo data, it performed similarly to TDFDFit with a 2% better fit in terms of mean squared error while obtaining a 169‐fold speedup.Conclusion: TensorFit enables fast and robust metabolite fitting in large MRSI data sets compared with conventional metabolite fitting methods. This tool could boost the clinical applicability of large 3D MRSI by enabling the fitting of large MRSI data sets within computation times acceptable in a clinical environment.


  • Open Access

    Simultaneous multi-region detection of GABA+ and Glx using 3D spatially resolved SLOW-editing and EPSI-readout at 7T

    by Guodong Weng, Johannes Slotboom, Philippe Schucht, Ekin Ermiş, Roland Wiest, Stefan Klöppel, Jessica Peter, Irena Zubak, Piotr Radojewski


  • Open Access

    Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MR

    by Guodong Weng, Ekin Ermiş, Theoni Maragkou, Reinhardt Krcek, Philipp Reinhardt, Irena Zubak, Philippe Schucht, Roland Wiest, Johannes Slotboom, Piotr Radojewski

    Background: 2-hydroxy-glutarate (2HG) is a metabolite that accumulates in isocitrate dehydrogenase (IDH)-mutated gliomas and can be detected noninvasively using MR spectroscopy. However, due to the low concentration of 2HG, established magnetic resonance spectroscopic imaging (MRSI) techniques at the low field have limitations with respect to signal-to-noise and to the spatial resolution that can be obtained within clinically acceptable measurement times. Recently a tailored editing method for 2HG detection at 7 Tesla (7 T) named SLOW-EPSI was developed. The underlying prospective study aimed to compare SLOW-EPSI to established techniques at 7 T and 3 T for IDH-mutation status determination.Methods: The applied sequences were MEGA-SVS and MEGA-CSI at both field strengths and SLOW-EPSI at 7 T only. Measurements were performed on a MAGNETOM-Terra 7 T MR-scanner in clinical mode using a Nova 1Tx32Rx head coil and on a 3 T MAGNETOM-Prisma scanner with a standard 32-channel head coil.Results: Fourteen patients with suspected glioma were enrolled. Histopathological confirmation was available in 12 patients. IDH mutation was confirmed in 9 out of 12 cases and 3 cases were characterized as IDH wildtype. SLOW-EPSI at 7 T showed the highest accuracy for IDH-status prediction (91.7% accuracy, 11 of the 12 predictions correct with 1 false negative case). At 7 T, MEGA-CSI had an accuracy of 58.3% and MEGA-SVS had an accuracy of 75%. At 3 T, MEGA-CSI showed an accuracy of 63.6% and MEGA-SVS of 33.3%. The co-edited cystathionine was detected in 2 out of 3 oligodendroglioma cases with 1p/19q codeletion.Conclusions: Depending on the pulse sequence, spectral editing can be a powerful tool for the noninvasive determination of the IDH status. SLOW-editing EPSI sequence is the preferable pulse sequence when used at 7 T for IDH-status characterization.


  • Open Access

    SLOW: A novel spectral editing method for whole‐brain MRSI at ultra high magnetic field

    by Guodong Weng, Piotr Radojewski, Sulaiman Sheriff, Claus Kiefer, Philippe Schucht, Roland Wiest, Andrew A. Maudsley, Johannes Slotboom

    Purpose: At ultra‐high field (UHF), B1+‐inhomogeneities and high specific absorption rate (SAR) of adiabatic slice‐selective RF‐pulses make spatial resolved spectral‐editing extremely challenging with the conventional MEGA‐approach. The purpose of the study was to develop a whole‐brain resolved spectral‐editing MRSI at UHF (UHF, B0 ≥ 7T) within clinical acceptable measurement‐time and minimal chemical‐shift‐displacement‐artifacts (CSDA) allowing for simultaneous GABA/Glx‐, 2HG‐, and PE‐editing on a clinical approved 7T‐scanner.Methods: Slice‐selective adiabatic refocusing RF‐pulses (2π‐SSAP) dominate the SAR to the patient in (semi)LASER based MEGA‐editing sequences, causing large CSDA and long measurement times to fulfill SAR requirements, even using SAR‐minimized GOIA‐pulses. Therefore, a novel type of spectral‐editing, called SLOW‐editing, using two different pairs of phase‐compensated chemical‐shift selective adiabatic refocusing‐pulses (2π‐CSAP) with different refocusing bandwidths were investigated to overcome these problems.Results: Compared to conventional echo‐planar spectroscopic imaging (EPSI) and MEGA‐editing, SLOW‐editing shows robust refocusing and editing performance despite to B1+‐inhomogeneity, and robustness to B0‐inhomogeneities (0.2 ppm ≥ ΔB0 ≥ −0.2 ppm). The narrow bandwidth (∼0.6–0.8 kHz) CSAP reduces the SAR by 92%, RF peak power by 84%, in‐excitation slab CSDA by 77%, and has no in‐plane CSDA. Furthermore, the CSAP implicitly dephases water, lipid and all the other signals outside of range (≥ 4.6 ppm and ≤1.4 ppm), resulting in additional water and lipid suppression (factors ≥ 1000s) at zero SAR‐cost, and no spectral aliasing artifacts.Conclusion: A new spectral‐editing has been developed that is especially suitable for UHF, and was successfully applied for 2HG, GABA+, PE, and Glx‐editing within 10 min clinical acceptable measurement time.